An active pharmaceutical ingredient or bulk material listed with the FDA but not in a finished dosage form.
Unfinished drug listings appear in FDA data with NDC-like identifiers but are never billable on a medical or pharmacy claim. They exist so that the agency can trace ingredient supply.